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Background: Cordyceps militaris has been used in traditional 
medicine to treat numerous diseases and has been reported 
to possess both antitumor and immunomodulatory activities 
in vitro and in vivo. However, the pharmacological and bio-
chemical mechanisms of Cordyceps militaris extract (CME) 
on macrophages have not been clearly elucidated. In the 
present study, we examined how CME induces the pro-
duction of proinflammatory cytokines, transcription factor, 
and the expression of co-stimulatory molecules. Methods: 
We confirmed the mRNA and protein levels of proin-
flammatory cytokines through RT-PCR and western blot 
analysis, followed by a FACS analysis for surface molecules. 
Results: CME dose dependently increased the production of 
NO and proinflammatory cytokines such as IL-1β, IL-6, 
TNF-α, and PGE2, and it induced the protein levels of iNOS, 
COX-2, and proinflammatory cytokines in a concentration- 
dependent manner, as determined by western blot and 
RT-PCR analysis, respectively. The expression of co-stim-
ulatory molecules such as ICAM-1, B7-1, and B7-2 was also 
enhanced by CME. Furthermore, the activation of the nu-
clear transcription factor, NF-κB in macrophages was 
stimulated by CME. Conclusion: Based on these ob-
servations, CME increased proinflammatory cytokines 
through the activation of NF-κB, further suggesting that 
CME may prove useful as an immune-enhancing agent in the 
treatment of immunological disease.
[Immune Network 2010;10(2):55-63]
INTRODUCTION
Cordyceps militaris is also known as the rare Chinese cater-
pillar fungus (1) and has benefits for the human body includ-
ing effects on the circulatory, immune, respiratory, and glan-
dular systems. It is commonly used in the orient to replenish 
the kidneys and soothe the lung as well as in the treatment 
of  hyperglycemia,  hyperlipidemia  (2,3),  renal  dysfunction, 
and liver disease (4); it is also thought to have anti-mutagenic 
(5)  and  anti-angiogenesis  (6)  capabilities.  Recently,  several 
studies demonstrated that extracts of Cordyceps militaris had 
multiple  pharmacological  actions  which  included  anti-in-
flammatory activity (6), improvement of insulin resistance and 
insulin secretion (2), and tumor suppression activity. Addition, 
it possesses antioxidant activity to a greater extent than Cor-
dyceps sinensis or Cordyceps kyushuensis (7). Because natu-
ral Cordyceps militaris is rare and expensive, many scientists 
have examined its life cycle with the aim of developing tech-
niques for the isolation of fermentable strains. Even though 
the immunomodulatory role of CME in immune response is 
being explored and further elucidated, the regulatory effects 
of CME on specific functions of macrophages has yet to be 
fully  explained.
    Macrophages, a type of differentiated tissue cell which orig-
inate as blood monocytes, play an important role in immune 
and allergic reactions as well as in inflammation (8). These 
cells have several functions including the killing and removal Immunostimulatory Effects of CME via the Activation of NF-κB
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of pathogenic microbes and the processing and presentation 
of  antigens  which  have  been  ingested  by  lymphocytes  (9). 
Macrophages are essential cellular components of the body's 
host defense system, playing critical roles in both innate and 
adaptive  immunity.  Also,  these  cells  collaborate  extensively 
with  T  cells  through  cell-cell  and  cytokine-mediated  inter-
actions  to  coordinate  the  evolution  of  inflammatory 
responses. In response to microbes and their products, such 
as lipopolysaccharide (LPS), macrophages secrete various in-
flammatory cytokines including interleukin (IL)-1β, IL-6, IL- 
12, and tumor necrosis factor (TNF)-α through the activation 
of nuclear factor (NF)-κB; they also express NF-κB-depend-
ent inducible nitric oxide (NO) synthase (iNOS) (10,11) and 
cyclooxygenase-2 (COX-2) (12). Many diseases, such as rheu-
matoid  arthritis  (RA),  arteriosclerosis,  chronic  hepatitis,  and 
pulmonary fibrosis (13-16) involve the overproduction of in-
flammatory  mediators.  Although  large  amounts  of  macro-
phage-derived proinflammatory mediators can cause several 
immune diseases, proper regulation of macrophage function 
by  immunomodulating  agents  could  help  protect  the  host 
from  various  pathogenic  and  cancerous  attacks.
    Nuclear factor-κB, a nuclear transcription factor, regulates 
the  expression  of  various  genes,  including  IL-1β,  TNF-α, 
iNOS, and COX-2, that play critical roles in apoptosis, tumori-
genesis, various autoimmune diseases, and inflammation (17,18). 
Because  of  its  ubiquitous  role  in  the  pathogenesis  of  in-
flammatory gene expression, NF-κB is currently a target for 
treating various diseases (19). Nuclear factor -κB is activated 
in response to various inflammatory stimuli, including bacte-
rial LPS, cytokines, and viral proteins (20). Under normal con-
ditions, NF-κB is present in the cytoplasm as an inactive het-
ero-trimer consisting of p50, p65, and IκBα subunits. Upon 
activation, degradation of IκBα exposes a localization signal 
on the p50/p65 hetero-dimer leading to nuclear translocation 
and to its binding to a specific sequence in several promoters 
which, in turn results in the transcription of proinflammatory 
genes.
    Given  that  these  effects  have  been  suggested  to  play  an 
important  role  in  disease  therapy,  we  investigated  whether 
CME could increase the production of proinflammatory medi-
ators  in  macrophages.
MATERIALS AND METHODS
Reagents
Lipopolysaccharide  (LPS)  was  purchased  from  Sigma  (St. 
Louis, USA). Cell culture media DMEM, antibiotic-penicillin/ 
streptomycin solution, and fetal bovine serum (Hyclone, Logan, 
USA)  were  used  for  the  cell  culture.
Preparation of CME from Cordyceps militaris 
Cultures of fruiting bodies of Cordyceps militaris were sup-
plied  by  CM  Biotec,  Kangnung,  Korea  and  identified  by 
Professor Jae-Mo Sung (Department of Agricultural Biology of 
Kangwon National University). The dried cultured fruit bodies 
were  extracted  with  distilled  deionized  water  (DDW)  for  6 
hrs at 60
oC. The water extracts were concentrated with a vac-
uum evaporator at 70
oC then lyophilized. Cordyceps militaris 
extract (CME) was included the cordycepin (3'-deoxyadenosine) 
1.3 ng/mg which was purchased from Sigma (St. Louis. MO, 
USA).
Cell culture
RAW264.7 mouse macrophage cells (American Type Culture 
Collection)  were  maintained  in  D u l b e c c o ' s  M o d i f i e d  E a g l e ' s 
Medium  (DMEM),  supplemented  with  10%  heat-inactivated 
fetal bovine serum (FBS; Hyclone, USA), 100 U/ml of pen-
icillin, and 100 g/ml of streptomycin (Hyclone, USA) at 37
oC 
in a 5% CO2 incubator. Primary macrophages were collected 
from  the  peritoneal  cavities  of  mice  (8-week-old  male  ICR 
mice) after an intraperitoneal (i.p.) injection of 3 ml of 3% 
thioglycolate  broth  (Sigma,  St.  Louis,  MO)  4  days  before 
harvesting.  The  peritoneal  macrophages  were  then  washed 
with 1×PBS (Ca2＋- and Mg2＋-free) and plated with DMEM 
containing  10%  FBS,  100  U/ml  of  penicillin,  and  100  U/ml 
of  streptomycin  at  37
oC  i n  a  5 %  C O 2  incubator.
MTT assay for cell viability
A commercially-available cell viability assay was employed to 
evaluate  the  cytotoxic  effect  of  cordycepin  using  thiazolyl 
blue tetrazolium bromide (Sigma, St. Louis, USA). RAW264.7 
cells  (2×10
5  cells/well)  were  plated  with  various  concen-
trations of CME in 96-well microtiter plates (Nunc, Roskilde, 
Denmark) and were then cultured overnight at 37
oC in a 5% 
CO2 incubator. Afterwards, 50μl of MTT solution was added 
to each well, and the cells were then cultured for 4 hrs at 
37
oC in a 5% CO2 incubator. 100μL of solubilized solution 
w e r e  a d d e d  t o  e a c h  w e l l .  T h e  p l a t e  w a s  a l l o w e d  t o  s t a n d 
overnight in the incubator after evaluation for complete sol-
ubilization of the purple formazan crystals and measurement 
of the optical density (OD) at 560 nm by a microplate reader 
(Molecular  Devices  corporation,  Sunnyvale,  USA).Immunostimulatory Effects of CME via the Activation of NF-κB
Seulmee Shin, et al.
57 IMMUNE NETWORK http://www.ksimm.or.kr Volume 10 Number 2 April 2010
Measurement of NO and PGE2
The amount of nitrite and PGE2 produced by mouse macro-
phages was measured in cell culture supernatant. The cells 
were plated at a density of 1×10
6 cells in a flat-bottomed, 
96-well plates with the 200μl of culture medium. They were 
then  treated  with  various  concentrations  (12.5∼200μg/ml) 
of CME in the absence of LPS (10 ng/ml) and incubated for 
overnight. NO production was determined according to the 
method reported by Stuehr and Nathan (21). The amount of 
nitrite was measured using the Griess reagent (stock-I: 0.2% 
N-(1-naphthyl)  ethylenediamine-HCl,  stock-II:  2%  sulfanila-
mide in 5% H 2PO4) and the amount of PGE2 produced was 
measured  using  an  enzyme-linked  immunosorbent  assay 
(ELISA) kit (R&D system, Minneapolis, MI, USA), according 
to  the  manufacturer's  instructions.
Cytokine assays
The amount of TNF-α, IL-1β, and IL-6 in the cell culture 
supernatant were measured using an ELISA kit (eBioscience, 
S a n  D i e g o ,  C A ,  U S A ) .  R A W  2 6 4 . 7  c e l l s  w e r e  c u l t u r e d  i n  
DMEM  with  10%  FBS  in  12-well,  flat-bottomed  plates  at  a 
density of 5×10
5 cells/well. The cells were treated with vari-
ous concentrations (12.5, 25, 50, 100, 200μg/ml) of CME in 
t h e  a b s e n c e  o r  p r e s e n c e  o f  L P S  ( 5 0  n g / m l )  a t  3 7
oC  for  48 
hrs in humidified air with 5% CO2. Subsequently, the culture 
supernatant was collected and assayed according to the man-
ufacturer's  instructions.
Isolation of total RNA and RT-PCR
T o t a l  R N A  w a s  e x t r a c t e d  f r o m  R A W 2 6 4 . 7  c e l l s  u s i n g  t h e  
RNeasy  Mini  kit  (QIAGEN,  USA)  in  an  RNase-free  environ-
ment. RNA was quantified by reading the absorbance at 260 
nm as previously described (14). The reverse transcription of 
1μg RNA was carried out using M-MLV reverse transcriptase 
(Promega, USA), oligo (dT) 16 primer, dNTP (0.5μM), and 
1 U RNase inhibitor. After incubation at 65
oC for 5 min and 
37
oC for 60 min, M-MLV reverse transcriptase was inactivated 
by heating at 70
oC for 15 min. The polymerase chain reaction 
(PCR)  was performed in  50 mM KCl, 10  mM  Tris-HCl  (pH 
8.3), 1.5 mM MgCl2, and 2.5 mM dNTPs with 5 units of Taq 
D N A  p o l y m e r a s e  a n d  1 0  p M  o f  e a c h  p r i m e r  s e t  f o r  i N O S ,  
PGE2,  IL-1β, IL-6, and PGE2. The cDNA was amplified by 
35 cycles of denaturing at 94
oC for 45 s, annealing at 62
oC 
for  45  s,  and  extension  at  72
oC  for  1  min.  Final  extension 
was performed at  72
oC  for  5  min.  The  PCR  products were 
electrophoresed on a 1.5% agarose gels and stained with ethi-
dium  bromide.  The  primers  used  were  5'  AGCTCCTCCCA 
GGACCACAC 3' (forward) and  5' ACGCTGAGTACCTCATTGGC 
3 '  ( r e v e r s e )  f o r  i N O S ,  5 '  C A G G A T G A G A C A T G A C A C C  3 '  
(forward)  and  5'  CTCTGCAGACTCAAACTCCAC  3'  (reverse) 
for IL-1β, 5' GTACTCCAGAAGACCAGAGG 3' (forward) and 
5'  TGCTGGTGACAACCACGGCC  3'  (reverse)  for  IL-6,  5' 
TTGACCTCAGCGCTGAGTTG 3' (forward) and 5' CCTGTAGC 
C C A C G T C G T A G C  3 '  ( r e v e r s e )  f o r  T N F - α,  5'  AAGAAGAAA 
GTTCATTCCTGATCCC 3' (forward) and 5' TGACTGTGGGA 
GGATACATCTCTC  3'  (reverse)  for  COX-2,  and  5'  GTGGG 
CCGCCCTAGGACCAG  3'  (forward)  and  5'  GGAGGAAGA 
GGATGCGGCAGT 3' (reverse) for β-actin. β-actin was used 
a s  a n  i n t e r n a l  c o n t r o l .
Preparation of nuclear extracts
After  cultured  cells  were  collected  and  washed  twice  with 
cold PBS, they were resuspended in hypotonic buffer (10 mM 
HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.2 mM PMSF, 
0.5 mM DTT, 10μg/ml aportinin). After 15 min incubation 
on ice, the cells were lysed by the addition of 0.1 % NP-40 
and vigorous vortexing for 1 min. The nuclei were pelleted 
by  centrifugation  at  12,000×g  for  1  min  at  4
oC  and  re-
suspended in high salt buffer (20 mM HEPES, pH 7.9, 25% 
glycerol, 400 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM 
DTT, 1 mM NaF, 1 mM sodium orthovanadate). The super-
natant  fluid  was  stored  in  aliquots  at  −70
oC.
Western blot analysis 
RAW 264.7 cells were washed with phosphate-buffered saline 
(PBS) and lysed by lysis buffer (1% SDS, 1.0 mM sodium va-
nadate, 10 mM Tris-Cl buffer, pH 7.4) for 5 min. 20μg of 
protein from the cell lysates was applied to 8∼12% SDS-poly-
acrylamide gels and then transferred to nitrocellulose mem-
branes. The membranes were blocked with 5% skim milk in 
PBST solution for 1 hr. They were then incubated with an-
ti-IL-1β,  anti-IL-6,  anti-TNF-α,  anti-i-NOS,  anti-COX-2,  and 
anti-NF-κB monoclonal antibodies (Santa Cruz Biotechnology 
I n c . ,  S a n t a  C r u z ,  C a l i f o r n i a ,  U S A )  f o r  2  h r s  a n d  w a s h e d  3  
times with PBST. After incubation with an alkaline phospha-
tase-labeled  secondary  antibody  (Abcam,  Cambridge,  USA) 
for 2 hrs, the bands were visualized using a Western Blot Kit 
with alkaline phosphatase substrate (Vector, Burlingame, USA).
Flow cytometry
RAW  264.7  cells  (1×10
6  cells/ml)  were  cultured  in  Petri- 
dishes.  The  cells  were  treated  with  various  concentrations Immunostimulatory Effects of CME via the Activation of NF-κB
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Figure 1. Effects of CME on NO and PGE2 production in macrophages. (A) RAW 264.7 cells and (B) peritoneal macrophages were treated with
various concentrations (12.5, 25, 50, 100, 200μg/ml) of CME or LPS (10 ng/ml), then incubated overnight. Nitrite levels in culture media were
determined using Griess reagent and were presumed to reflect NO levels. (C) RAW 264.7 cells and (D) peritoneal macrophages were treated
with 12.5∼200μg/ml of CME for 48 hrs. Levels of PGE2 in culture media were quantified using EIA kits. Data are presented as means±S.D.
of three independent experiments. 
†p＜0.01 vs. cells only; *p＜0.05, **p＜0.01 vs. cells only.
(12.5, 50, 200 μg/ml) of CME in the absence or presence 
of  LPS  (100  ng/ml).  the  dishes  were  incubated  at  37
oC for 
2 4  h r s  i n  h u m i d i f i e d  5 %  C O 2  incubator  under  standard 
conditions. The cells were then washed with PBS. The wash-
ed  cells  were  blocked  with  staining  buffer  containing  10% 
normal mouse serum (NMS) for 20 min on ice. The blocked 
cells  were  incubated  with  co-stimulatory  molecules  such  as 
ICAM-1, B7-1 and B7-2 antibody (BD Biosciences, San Jose, 
USA)  for 20  min  on  ice. The incubated  cells  were washed 
three times with staining buffer and then fixed by 1% paraf-
ormaldehyde in PBS. The fixed cells were measured by flow 
cytometry  (Beckman  coulter,  Brea,  USA).
Data analysis  
D a t a  a r e  e x p r e s s e d  a s  m e a n ± s t a n d a r d  d e v i a t i o n .  S t a t i s t i c a l  
significance between the groups was determined by a paired 
t-test and one-way ANOVA for repeated measures. Results of 
p＜0.05  were  considered  statistically  significant.  Data  were 
assessed using SPSS (version 15.0, SPSS Inc., Chicago, Illinois).Immunostimulatory Effects of CME via the Activation of NF-κB
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Figure 2. Effects of CME on the expression of iNOS and COX-2 
protein and mRNA in macrophages. (A) RAW 264.7 cells were treated
with various concentrations (12.5, 25, 50, 100, 200μg/ml) of CME 
or LPS (100 ng/ml) for 24 hrs. Total cellular proteins (20μg) were 
resolved by SDS-PAGE, transferred to nitrocellulose membranes, and 
detected with specific antibodies, as described in Materials and 
Methods. (B) Cells were treated as described above. Total RNA was 
prepared for the RT-PCR analysis of the expression of iNOS and 
COX-2 in macrophages treated with various concentrations (12.5, 25,
50, 100, 200 μg/ml) of CME or LPS (100 ng/ml) for overnight. 
iNOS-specific sequences and COX-2-specific sequences were detected
by agarose gel electrophoresis, as described in Materials and Methods.
PCR for β-actin was performed to verify that the initial cDNA 
contents of the samples were similar. This was repeated in triplicate 
and similar results were obtained in all three.
RESULTS
CME enhances NO and PGE2 production in macro-
phages  
To analyze the potential proinflammatory properties of CME, 
we used murine macrophages, which produces NO and PGE2. 
Nitric oxide is known to represent toxic and proinflammatory 
mediators in acute and chronic inflammatory diseases as well 
as in normal defense reactions. In the current study, macro-
phages did not release NO in response to the medium alone; 
LPS (10 ng/ml) was used as a positive control for macrophage 
activation (Fig. 1A and B). When various concentrations of 
CME (12.5, 25, 50, 100, 200μg/ml) were added to the culture 
media at the time of cell stimulation (18 hrs), NO production 
increased in a CME concentration-dependent manner (Fig. 1A 
and  B).  Further,  CME  was  also  found  to  dose-dependently 
increase PGE2 production (Fig. 1C and D). The potential cy-
toxicity of CME was evaluated by MTT assay after incubating 
cells for 24 hrs in the absence or presence of LPS. Results 
revealed  that  viability  was  unaffected  at  the  concentrations 
used to enhance NO and PGE2 (data not shown). Thus, the 
immune  enhancement  was  not  attributable  to  a  cytotoxic 
effect.
CME regulates the mRNA and protein expression of 
iNOS and COX-2 
R T - P C R  a n d  w e s t e r n  b l o t  a n a l yses  were  performed  to  de-
termine whether CME had a direct effect on proinflammatory 
mediators  (NO  and  PGE2)  related  to  modulation  of  the  ex-
pression of iNOS and COX-2. As shown in Fig. 2A, iNOS and 
COX-2 protein expression was markedly induced in macro-
phage cells after treatment both with CME and LPS. This in-
duction was increased by CME treatment in a dose-depend-
ently manner. Furthermore, RT-PCR analysis revealed that the 
expression of the COX-2 gene was correlated with their pro-
tein  levels  (Fig.  2B).
Direct cytokines production in response to CME 
To determine whether CME had a direct effect on cytokine 
production,  IL-1β,  IL-6,  and  TNF-α secretion  were  meas-
ured in the macrophage cell line using cytokine ELISA kits. 
IL-1β, IL-6, and TNF-α, are the major proinflammatory cyto-
kines produced by monocytes and macrophages. As shown 
in Fig. 3, CME dose-dependently increased cytokine produc-
tion.  Interestingly,  CME  also  strongly  increased  IL-1β and 
IL-6  production. 
CME regulates the gene and protein expression of 
proinflammatory cytokines
To further investigate the important role of CME on immune 
response,  inducing  RAW  264.7  cells  for  24  hours  with  LPS 
or  CME  resulted  in  the  production  of  proinflammatory 
cytokines. As shown in Fig. 4A, CME concentration-depend-
ently induced the expression of IL-1β, IL-6, and TNF-α pro-
tein  and  mRNA  (Fig.  4B).
CME strongly modulates the surface expression 
levels of co-stimulatory molecules
Further to evaluate whether CME influences the phenotypic 
maturation of macrophages were cultured with CME or LPS 
for  24  h  and  then  analyzed  for  any  surface  expression  of 
ICAM-1, B7-1, and B7-2 molecules. As shown in Fig. 5, CME 
similarly  to  LPS,  induced  dramatic  up-regulation  of  ICAM-1 
and  B7-1/-2  molecules.
CME induces of NF-κB activation
It has been shown that NF-κB activation is a critical factor Immunostimulatory Effects of CME via the Activation of NF-κB
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Figure 3. Effect of CME on cytokine production in RAW 264.7 cells. 
Effects of CME on IL-1β (A), IL-6 (B), and TNF-α (C) production in
macrophages. Cultures were treated with various concentrations of 
CME (12.5, 25, 50, 100, 200μg/ml). The supernatants were collected,
and the extracellular levels of cytokines were measured in culture 
media using cytokine ELISA kits. The results are reported as mean±S.D.
of three independent experiments. 
†p＜0.01 vs. cells only; *p＜0.05, 
**p＜0.01 vs. cells only.
for the expression of various cytokines, iNOS, and COX-2 in 
macrophages in response to LPS. In an unstimulated cell, NF-
κB  resides  in  the  cytoplasm  as  an  inactive  NF-κB  /IκB 
complex. Under stimuli, IκBα is phosphorylated and sub-
sequently degraded, allowing NF-κB to translocate into the 
nucleus  (13).  To  investigate  whether  CME  could  affect  nu-
clear translocation of NF-κB, a western blot analysis for NF-
κB p65 was carried out with cell lysate in macrophages (Fig. 
6). The amount of NF-κB p65 markedly increased upon ex-
posure  to  LPS  alone;  CME  also  increased  NF-κB  p65.
DISCUSSION
The data presented in this paper indicated that CME can exert 
significant immunomodulatory effects on macrophage-mediated 
immune responses. The present study demonstrated that CME 
is an effective activator of NO generation, cytokine (IL-1β, 
IL-6,  and  TNF-α)  expression,  PGE2  secretion,  and  co-stim-
ulatory  molecules  in  macrophages.  Inflammation  is  a  com-
p l e x  p r o c e s s  i n v o l v i n g  n u m e r o u s  m e d i a t o r s  o f  c e l l u l a r  a n d  
plasma origins. Activated macrophages fuse their lysosomes 
more efficiently to phagosomes, exposing intracellular or re-
cently ingested extracellular microbes to a variety of micro-
biocidal lysosomal enzymes. Activated macrophages also pro-
duce oxygen radicals and NO, both of which have potent an-
timicrobial activity. Furthermore, they synthesize anti-micro-
bial peptides and proteases that can be released to attract ex-
tracellular  parasites.  Additional  changes  in  activated  macro-
phages  assist  in  amplifying  the  immune  response. 
    Nitric oxide has been known to play a critical role in pre-Immunostimulatory Effects of CME via the Activation of NF-κB
Seulmee Shin, et al.
61 IMMUNE NETWORK http://www.ksimm.or.kr Volume 10 Number 2 April 2010
Figure 4. Effects of CME on the expression of pro-inflammatory 
cytokines proteins and mRNA in macrophages. (A) RAW 264. 7 cells
were treated with various concentrations (12.5, 25, 50, 100, 200μ
g/ml) of CME or LPS (100 ng/ml) for 24 hrs. Total cellular proteins 
(20μg) were resolved by SDS-PAGE, transferred to nitrocellulose 
membranes, and detected with specific antibodies, as described in the
Materials and Methods. (B) Cells were treated as described above. 
Total RNA was prepared for the RT-PCR analysis of the expression
of IL-1β, IL-6, and TNF-α in macrophages treated with various 
concentrations (12.5, 25, 50, 100, 200μg/ml) of CME or LPS (100 
ng/ml) for overnight. IL-1β-specific sequences, IL-6-specific sequen-
ces, and TNF-α-specific sequences were detected by agarose gel 
electrophoresis, as described in Materials and Methods. PCR for β- 
actin was performed to verify that the initial cDNA contents of the 
samples were similar. The experiment was repeated in triplicate and
similar results were obtained in all three.
vention  against  microbial  infection  and  cancer  occurrence 
(23,24). In addition, NO may be involved with regulation of 
apoptosis (25) and progression of autoimmune disease by al-
tering the differentiation of the helper T cell phenotype (26). 
The biological activity of NO has become more complicated 
since NO production was reported to suppress the functional 
activity of T lymphocytes and antigen presenting cells (APCs) 
(27). In this paper, we have demonstrated that CME induced 
an  increase  of  NO  production  in  vitro  (Fig.  1  and  2).
    Prostaglandins, which are produced by COX-2, have been 
implicated  as  important  mediators  in  endotoxemia  and  in-
flammatory conditions (28). For example, PGE2, like NO, is 
a  pleiotropic  mediator  produced  at  inflammatory  sites  by 
COX-2  that  gives  rise  to  pain,  swelling  and  stiffness  (29). 
Here, we have demonstrated that CME significantly increases 
the gene expression of COX-2 and PGE2 production in macro-
phage  cells  (Fig.  1  and  2).
    Cytokines are local protein mediators and are involved in 
almost  all  important  biological  processes  including  cell 
growth and activation, inflammation, immunity, and differen-
tiation. In this study, CME dose-dependently enhanced IL-1β, 
IL-6 and TNF-α production in RAW 264.7 cells (Fig. 3 and 
4). 
  The expression of cytokines requires the activation of NF-
κB ,  a  n u c l e a r  t r a n s c r i p t i o n  f a c t o r ,  w h i c h  r e g u l a t e s  t h e  e x-
pression  of  various  genes,  including  IL-1β,  i-NOS,  and 
COX-2 all of which play critical roles in apoptosis and auto-
immune disease. Nuclear factor-κB requires the phosphor-
ylation of IκB and then targets IκB for ubiquitination and 
degradation.  As  shown  in  Fig.  6,  CME  increased  proin-
f l a m m a t o r y  m e d i a t o r s  v i a  N F - κB  activation  in  RAW  264.7 
cells.
    The  intracellular  adhesion  molecules  (ICAMs),  ICAM-1, 
ICAM-2  and  ICAM-3,  are  cell  surface  ligands  for  leukocyte 
integrins. They are crucial in the binding of lymphocytes and 
other leukocytes to certain cells including APCs. In the cur-
rent  study,  CME  induced  the  ICAM-1  molecules  in  macro-
phages (Fig. 5A). The B7 family plays an important role as 
a co-stimulatory factor in APCs. Treatment with CME had an-
other  major  effect  on  co-stimulatory  molecules  B7-1/-2  by 
strongly upregulating the surface levels of B7-1/-2 molecules 
in macrophage cells (Fig. 5B, C). All these molecules have 
been described to be of major importance in APC function 
(30,31). 
    In summary, the finding of the present study suggest that 
CME isolated from the fruiting bodies of Cordyceps militaris 
is a potent activator of NO, PGE2, and proinflammation pro-
duction  in  macrophages,  and  that  it  acts  at  the  level  of 
transcription. Moreover, these inductions of the immune re-
action  by  CME  were  associated  with  NF-κB  activation.  In 
conclusion,  CME  has  immunostimulatory  effects  on  macro-
phages through an enhancement of the production of cyto-
kines and other bioactive substances as well as through the 
increased expression of co-stimulatory and adhesion molecules. 
In conclusion, together with these facts of our finding suggest 
that CME might be useful as a therapeutic agent for the treat-
ment  of  the  immune  deficiency  diseases. 
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Figure 5. Effects of CME on the expression of co-stimulatory molecules in RAW 264.7 cells. Cells were cultured with various concentrations
of CME (12.5, 50, 200μg/ml) or LPS (100 ng/ml) for 24 hrs. Surface ICAM-1 (A), B7-1 (B), and B7-2 (C) molecules were labeled with either
anti-ICAM-1 or anti-B7-1/-2.
Figure 6. Effects of CME on NF-κB activation in RAW 264.7 cells.
Cells were incubated overnight with various concentrations of CME 
(12.5∼200μg/ml) in the absence or presence of LPS (100 ng/ml). 
Protein (20μg) from each sample was resolved in 12% SDS-PAGE
and then analyzed by western blotting. β-actin was used as a control.
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